[1]
“Strengthening post-market drug surveillance in Nepal: evidence, gaps, and pathways forward”, J Patan Acad Health Sci, vol. 12, no. 2, pp. 94–97, Dec. 2025, doi: 10.3126/jpahs.v12i2.89012.